Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.
You Might Also Like
Also By This Author
ad goes here:advert-1
SCROLL TO CONTINUE
- UCB Canada Inc. News release: Health Canada approves Cimzia (certolizumab pegol) for moderate to severe psoriasis. 2019 Mar 25.
- National Institute for Health and Care Excellence. Guidance: Certolizumab pegol for treating moderate to severe plaque psoriasis. 2019 Apr 17.